This expansion is crucial for meeting the rising global demand and positions the company to capitalize on emerging markets
Hunger plummets, portion sizes shrink, and the weight starts coming off
People with diabetes who need to lose weight should consider Semaglutide or one of the other GLP1 drugs (Bydureon, Trulicity, Victoza, Rybelsus-an oral form of Semaglutide)
Retrieved from US Food and Drug Administration (FDA-c)
TheODen, originally developed by Jonathan Stieber, is open source: #Oncopathology #FederatedLearning #ComputationalPathology #PharmaAI #LifeSciences To view or add a comment, sign in Publish in the Only PubMed-Indexed Journal for Decentralized Health - If you are working at the intersection of decentralized technology, AI, digital identity, cybersecurity, supply chain, or health data interoperability there is a global, peer reviewed home specifically built for your work
The FDA has not approved dual GLP-1 therapy, no clinical trials support this combination, and it would increase side effect risk without proven benefit